These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30475435)

  • 1. Gain-of-function variants in the ODC1 gene cause a syndromic neurodevelopmental disorder associated with macrocephaly, alopecia, dysmorphic features, and neuroimaging abnormalities.
    Rodan LH; Anyane-Yeboa K; Chong K; Klein Wassink-Ruiter JS; Wilson A; Smith L; Kothare SV; Rajabi F; Blaser S; Ni M; DeBerardinis RJ; Poduri A; Berry GT
    Am J Med Genet A; 2018 Dec; 176(12):2554-2560. PubMed ID: 30475435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel de novo pathogenic variant in the ODC1 gene in a girl with developmental delay, alopecia, and dysmorphic features.
    Bupp CP; Schultz CR; Uhl KL; Rajasekaran S; Bachmann AS
    Am J Med Genet A; 2018 Dec; 176(12):2548-2553. PubMed ID: 30239107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the phenotype: Four new cases and hope for treatment in Bachmann-Bupp syndrome.
    VanSickle EA; Michael J; Bachmann AS; Rajasekaran S; Prokop JW; Kuzniecky R; Hofstede FC; Steindl K; Rauch A; Lipson MH; Bupp CP
    Am J Med Genet A; 2021 Nov; 185(11):3485-3493. PubMed ID: 34477286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Role of
    Prokop JW; Bupp CP; Frisch A; Bilinovich SM; Campbell DB; Vogt D; Schultz CR; Uhl KL; VanSickle E; Rajasekaran S; Bachmann AS
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33806076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical features of primary cells from a pediatric patient with a gain-of-function
    Schultz CR; Bupp CP; Rajasekaran S; Bachmann AS
    Biochem J; 2019 Jul; 476(14):2047-2057. PubMed ID: 31249027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease.
    Rajasekaran S; Bupp CP; Leimanis-Laurens M; Shukla A; Russell C; Junewick J; Gleason E; VanSickle EA; Edgerly Y; Wittmann BM; Prokop JW; Bachmann AS
    Elife; 2021 Jul; 10():. PubMed ID: 34282722
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kato K; Miya F; Hamada N; Negishi Y; Narumi-Kishimoto Y; Ozawa H; Ito H; Hori I; Hattori A; Okamoto N; Kato M; Tsunoda T; Kanemura Y; Kosaki K; Takahashi Y; Nagata KI; Saitoh S
    J Med Genet; 2019 Jun; 56(6):388-395. PubMed ID: 30573562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8.
    Yasin H; Gibson WT; Langlois S; Stowe RM; Tsang ES; Lee L; Poon J; Tran G; Tyson C; Wong CK; Marra MA; Friedman JM; Zahir FR
    J Hum Genet; 2019 Apr; 64(4):271-280. PubMed ID: 30670789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel de novo MTOR gain-of-function variant in a patient with Smith-Kingsmore syndrome and Antiphospholipid syndrome.
    Rodríguez-García ME; Cotrina-Vinagre FJ; Bellusci M; Martínez de Aragón A; Hernández-Sánchez L; Carnicero-Rodríguez P; Martín-Hernández E; Martínez-Azorín F
    Eur J Hum Genet; 2019 Sep; 27(9):1369-1378. PubMed ID: 31053780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND).
    Vera G; Sorlin A; Delplancq G; Lecoquierre F; Brasseur-Daudruy M; Petit F; Smol T; Ziegler A; Bonneau D; Colin E; Mercier S; Cogné B; Bézieau S; Edery P; Lesca G; Chatron N; Sabatier I; Duban-Bedu B; Colson C; Piton A; Durand B; Capri Y; Perrin L; Wiesener A; Zweier C; Maroofian R; Carroll CJ; Galehdari H; Mazaheri N; Callewaert B; Giulianno F; Zaafrane-Khachnaoui K; Buchert-Lo R; Haack T; Magg J; Rieß A; Blandfort M; Waldmüller S; Horber V; Leonardi E; Polli R; Turolla L; Murgia A; Frebourg T; Lebre AS; Nicolas G; Saugier-Veber P; Guerrot AM
    Eur J Med Genet; 2020 Oct; 63(10):104004. PubMed ID: 32688057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Genotype-Phenotype Correlation in Children with KMT2E Gene-Related Neurodevelopmental Disorders: Report of Two New Cases and Review of Published Literature.
    Sharawat IK; Panda PK; Dawman L
    Neuropediatrics; 2021 Apr; 52(2):98-104. PubMed ID: 33111303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent NFIA K125E substitution represents a loss-of-function allele: Sensitive in vitro and in vivo assays for nontruncating alleles.
    Uehara T; Sanuki R; Ogura Y; Yokoyama A; Yoshida T; Futagawa H; Yoshihashi H; Yamada M; Suzuki H; Takenouchi T; Matsubara K; Hirata H; Kosaki K; Takano-Shimizu T
    Am J Med Genet A; 2021 Jul; 185(7):2084-2093. PubMed ID: 33973697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine decarboxylase and agmatinase: an alternative pathway for de novo biosynthesis of polyamines for development of mammalian conceptuses.
    Wang X; Ying W; Dunlap KA; Lin G; Satterfield MC; Burghardt RC; Wu G; Bazer FW
    Biol Reprod; 2014 Apr; 90(4):84. PubMed ID: 24648395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness.
    Kaminski L; Torrino S; Dufies M; Djabari Z; Haider R; Roustan FR; Jaune E; Laurent K; Nottet N; Michiels JF; Gesson M; Rocchi S; Mazure NM; Durand M; Tanti JF; Ambrosetti D; Clavel S; Ben-Sahra I; Bost F
    Cancer Res; 2019 Jul; 79(13):3268-3280. PubMed ID: 31064849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
    Okur V; Cho MT; Henderson L; Retterer K; Schneider M; Sattler S; Niyazov D; Azage M; Smith S; Picker J; Lincoln S; Tarnopolsky M; Brady L; Bjornsson HT; Applegate C; Dameron A; Willaert R; Baskin B; Juusola J; Chung WK
    Hum Genet; 2016 Jul; 135(7):699-705. PubMed ID: 27048600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
    Nabais Sá MJ; El Tekle G; de Brouwer APM; Sawyer SL; Del Gaudio D; Parker MJ; Kanani F; van den Boogaard MH; van Gassen K; Van Allen MI; Wierenga K; Purcarin G; Elias ER; Begtrup A; Keller-Ramey J; Bernasocchi T; van de Wiel L; Gilissen C; Venselaar H; Pfundt R; Vissers LELM; Theurillat JP; de Vries BBA
    Am J Hum Genet; 2020 Mar; 106(3):405-411. PubMed ID: 32109420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked intrafamilial variability of clinical and neuroimaging manifestations in NFIB-related developmental disorder.
    Gana S; Serpieri V; Giorgio E; Iorio M; Rognone E; Pichiecchio A; Chiappedi M; Valente EM
    Am J Med Genet A; 2023 May; 191(5):1395-1400. PubMed ID: 36756855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable Clinical Manifestations of Xia-Gibbs syndrome: Findings of Consecutively Identified Cases at a Single Children's Hospital.
    Ritter AL; McDougall C; Skraban C; Medne L; Bedoukian EC; Asher SB; Balciuniene J; Campbell CD; Baker SW; Denenberg EH; Mazzola S; Fiordaliso SK; Krantz ID; Kaplan P; Ierardi-Curto L; Santani AB; Zackai EH; Izumi K
    Am J Med Genet A; 2018 Sep; 176(9):1890-1896. PubMed ID: 30152016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel de novo mutation in CSNK2A1: reinforcing the link to neurodevelopmental abnormalities and dysmorphic features.
    Trinh J; Hüning I; Budler N; Hingst V; Lohmann K; Gillessen-Kaesbach G
    J Hum Genet; 2017 Nov; 62(11):1005-1006. PubMed ID: 28725024
    [No Abstract]   [Full Text] [Related]  

  • 20. Newly described clinical features in two siblings with MACS syndrome and a novel mutation in RIN2.
    Aslanger AD; Altunoglu U; Aslanger E; Satkın BN; Uyguner ZO; Kayserili H
    Am J Med Genet A; 2014 Feb; 164A(2):484-9. PubMed ID: 24449201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.